Healthcare Professional Insights
Receive regular headline summaries whenever high-quality news is generated for Healthcare Professional Insights. We'll never share your email address with others.
Shares Healthcare News With (link): | |
---|---|
Other Healthcare Entities | We are still establishing shared news links for this healthcare topic. |
Selected Headines
Date | Headline (link) | Source | Relevant Snippet |
---|---|---|---|
3/11/2020 | Crwe World | Ipsen Data Presented during ENETS Annual Conference 2020 Capture New Patient and Healthcare Professional Insights in the Treatment of NETs and Acromegaly | crweworld.com | March 11, 2020 06:00 UTC Ipsen Data Presented during ENETS Annual Conference 2020 Capture New Patient and Healthcare Professional Insights in the Treatment of NETs and Acromegaly - Studies include quantitative findings from patients and healthcare professionals, and new perspectives on somatostatin analogs in the management of neuroendocrine tumors (NETs) and acromegaly - Multinational PRESTO (nurse preference) study results simultaneously published as open access in peer-reviewed medical journal, Advances in Therapy ... |
3/11/2020 | Ipsen Data Presented during ENETS Annual Conference 2020 Capture New Patient and Healthcare Professional Insights in the Treatment of NETs and Acromegaly | Benzinga | Studies include quantitative findings from patients and healthcare professionals, and new perspectives on somatostatin analogs in the management of neuroendocrine tumors (NETs) and acromegaly - Multinational PRESTO (nurse preference) study results simultaneously published as open access in peer-reviewed medical journal, Advances in Therapy - Presentations showcase Ipsen's commitment to patient centricity, multi-stakeholder collaboration Regulatory News: Ipsen ((Euronext: IPN, OTC: IPSEY ) today announced the presentation of 13 new abstracts 1 during ... |
3/11/2020 | Ipsen Data Presented during ENETS Annual Conference 2020 Capture New Patient and Healthcare Professional Insights in the Treatment of NETs and Acromegaly | Business Wire | PARIS- Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced the presentation of 13 new abstracts 1 during the 17 th European Neuroendocrine Tumor Society (ENETS) Annual Conference, taking place virtually worldwide, (March 11-13, 2020) and the simultaneous publication of the PRESTO study in the medical journal, Advances in Therapy . 2 These data reinforce Ipsen’s personal approach to working with patients living with neuroendocrine tumors (NETs) and acromegaly, and healthcare ... |
3/11/2020 | Ipsen Data Presented during ENETS Annual Conference 2020 Capture New Patient and Healthcare Professional Insights in the Treatment of NETs and Acromegaly | BioSpace | Ipsen Data Presented during ENETS Annual Conference 2020 Capture New Patient and Healthcare Professional Insights in the Treatment of NETs and Acromegaly Published: Mar 11, 2020 March 11, 2020 06:00 UTC - Studies include quantitative findings from patients and healthcare professionals, and new perspectives on somatostatin analogs in the management of neuroendocrine tumors (NETs) and acromegaly - Multinational PRESTO (nurse preference) study results simultaneously published as open access in peer-reviewed medical ... |
3/11/2020 | Ipsen Data Presented during ENETS Annual Conference 2020 Capture New Patient and Healthcare Professional Insights in the Treatment of NETs and Acromegaly | financialbuzz.com | Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced the presentation of 13 new abstracts 1 during the 17 th European Neuroendocrine Tumor Society (ENETS) Annual Conference, taking place virtually worldwide, (March 11-13, 2020) and the simultaneous publication of the PRESTO study in the medical journal, Advances in Therapy . 2 These data reinforce Ipsen’s personal approach to working with patients living with neuroendocrine tumors (NETs) and acromegaly, and healthcare professionals ... |
3/11/2020 | Ipsen Data Presented During ENETS Annual Conference 2020 Capture New Patient and Healthcare Professional Insights in the Treatment of NETs | newswiretoday.com | Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How! • Studies include quantitative findings from patients and healthcare professionals, and new perspectives on somatostatin analogs in the management of neuroendocrine tumors (NETs) and acromegaly; • Multinational PRESTO (nurse preference) study results simultaneously published as open access in peer-reviewed medical journal ... |